Transcriptome alterations in HepG2 cells induced by shRNA knockdown and overexpression of TMEM2 gene

References

• Seto WK, Lo YR, Pawlotsky JM, et al. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313–2324. PubMed PMID: 30496122.
   PubMed Web of Science ®Google Scholar
• Tang LSY, Covert E, Wilson E, et al. Chronic hepatitis B infection: a review. JAMA. 2018;319(17):1802–1813. PubMed PMID: 29715359.
   PubMed Web of Science ®Google Scholar
• Hutin Y, Nasrullah M, Easterbrook P, et al. Access to treatment for hepatitis B virus infection - worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(28):773–777. PubMed PMID: 30025413.
   PubMed Web of Science ®Google Scholar
• Lancet, The. Towards elimination of viral hepatitis by 2030. Lancet. 2016;388(10042):308. PubMed PMID: 27477148.
   Web of Science ®Google Scholar
• Morikawa K, Suda G, Sakamoto N. Viral life cycle of hepatitis B virus: host factors and druggable targets. Hepatol Res. 2016;46(9):871–877. PubMed PMID: 26776362.
   PubMed Web of Science ®Google Scholar
• Nishitsuji H, Ujino S, Shimizu Y, et al. Novel reporter system to monitor early stages of the hepatitis B virus life cycle. Cancer Sci. 2015;106(11):1616–1624. PubMed PMID: 26310603.
   PubMed Web of Science ®Google Scholar
• Boeijen LL, Hoogeveen RC, Boonstra A, et al. Hepatitis B virus infection and the immune response: the big questions. Best Pract Res Clin Gastroenterol. 2017;31(3):265–272. PubMed PMID: 28774408.
   PubMed Web of Science ®Google Scholar
• Tsai KN, Kuo CF, Ou JJ. Mechanisms of hepatitis B virus persistence. Trends Microbiol. 2018;26(1):33–42. PubMed PMID: 28823759.
   PubMed Web of Science ®Google Scholar
• He Q, Huang Y, Zhang L, et al. Association between vitamin D receptor polymorphisms and hepatitis B virus infection susceptibility: a meta-analysis study. Gene. 2018;645:105–112. PubMed PMID: 29248582.
   PubMed Web of Science ®Google Scholar
• Kacprzak-Bergman I, Nowakowska B. Influence of genetic factors on the susceptibility to HBV infection, its clinical pictures, and responsiveness to HBV vaccination. Arch Immunol Ther Exp (Warsz). 2005;53(2):139–142. PubMed PMID: 15928582.
   PubMed Web of Science ®Google Scholar
• Moudi B, Heidari Z, Mahmoudzadeh-Sagheb H. Impact of host gene polymorphisms on susceptibility to chronic hepatitis B virus infection. Infect Genet Evol. 2016;44:94–105. PubMed PMID: 27346643.
   PubMed Web of Science ®Google Scholar
• Wrzesiński T, Szelag M, Cieślikowski WA, et al. Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors. BMC Cancer. 2015;15:518. 10.1186/s12885-015-1530-4. PubMed PMID: 26169495
   PubMed Web of Science ®Google Scholar
• Totong R, Schell T, Lescroart F, et al. The novel transmembrane protein Tmem2 is essential for coordination of myocardial and endocardial morphogenesis. Development. 2011;138(19):4199–4205. PubMed PMID: 21896630.
   PubMed Web of Science ®Google Scholar
• Smith KA, Lagendijk AK, Courtney AD, et al. Transmembrane protein 2 (Tmem2) is required to regionally restrict atrioventricular canal boundary and endocardial cushion development. Development. 2011;138(19):4193–4198. PubMed PMID: 21896629.
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Yamamoto H, Tobisawa Y, et al. TMEM2: a missing link in hyaluronan catabolism identified? Matrix Biol. 2019 May;78–79:139–146. PubMed PMID: 29601864; PubMed Central PMCID: PMCPMC6314907. eng.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Tobisawa Y, Inubushi T, et al. A mammalian homolog of the zebrafish transmembrane protein 2 (TMEM2) is the long-sought-after cell-surface hyaluronidase. J Biol Chem. 2017;292(18):7304–7313. PubMed PMID: 28246172.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Peng L, Huang W, et al. Rare inborn errors associated with chronic hepatitis B virus infection. Hepatology. 2012;56(5):1661–1670. PubMed PMID: 22610944.
   PubMed Web of Science ®Google Scholar
• Zhu X, Xie C, Li YM, et al. TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway. Cell Death Dis. 2016;7(6):e2239. PubMed PMID: 27253403.
   PubMedGoogle Scholar
• Li R, Yu C, Li Y, et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics. 2009;25(15):1966–1967. PubMed PMID: 19497933.
   PubMed Web of Science ®Google Scholar
• Mortazavi A, Williams BA, McCue K, et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5(7):621–628. PubMed PMID: 18516045.
   PubMed Web of Science ®Google Scholar
• Eisen MB, Spellman PT, Brown PO, et al. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998;95(25):14863–14868. PubMed PMID: 9843981.
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Araki M, Goto S, et al. KEGG for linking genomes to life and the environment. Nucleic Acids Res. 2008;36:D480–4. PubMed PMID: 18077471.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001 Dec;25(4):402–408. PubMed PMID: 11846609; eng.
   PubMed Web of Science ®Google Scholar
• Frodsham AJ, Zhang L, Dumpis U, et al. Class II cytokine receptor gene cluster is a major locus for hepatitis B persistence. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9148–9153. PubMed PMID: 16757563; PubMed Central PMCID: PMCPMC1482581. eng.
   PubMed Web of Science ®Google Scholar
• Chen J, Xu W, Chen Y, et al. Matrix metalloproteinase 9 facilitates hepatitis B virus replication through binding with type I interferon (IFN) receptor 1 to repress IFN/JAK/STAT signaling. J Virol. 2017 Apr 15;91(8). PubMed PMID: 28122987; PubMed Central PMCID: PMCPMC5375666. eng. DOI:10.1128/jvi.01824-16.
   Web of Science ®Google Scholar
• Tao J, Van Esch H, Hagedorn-Greiwe M, et al. Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation. Am J Hum Genet. 2004 Dec;75(6):1149–1154. PubMed PMID: 15499549; PubMed Central PMCID: PMCPMC1182152. eng.
   PubMed Web of Science ®Google Scholar
• Jena N, Martín-Seisdedos C, McCue P, et al. BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res. 1997 Jan 10;230(1):28–37. PubMed PMID: 9013703; eng.
   PubMed Web of Science ®Google Scholar
• Tang CL, Zhou Z, Shi WQ. [Effects of Fuzheng Huayu Capsule on the ratio of TGF-beta1/BMP-7 of chronic viral hepatitis B fibrosis patients of Gan-Shen insufficiency blood-stasis obstruction syndrome]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 2012 Jan;32(1):20–24. PubMed PMID: 22500384; chi.
   PubMedGoogle Scholar
• Cao H, Shu X, Chen LB et al., [The relationship of expression of BMP-7 in the liver and hepatic inflammation and fibrosis in patients with chronic HBV infection]. Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology. 2010 Apr;24(2):101–103. PubMed PMID: 21110425; chi.
   PubMedGoogle Scholar
• Alzahrani AS PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol. 2019 Dec;59:125–132. PubMed PMID: 31323288; eng.
   PubMed Web of Science ®Google Scholar
• Aoki M, Fujishita T. Oncogenic roles of the PI3K/AKT/mTOR axis. Curr Top Microbiol Immunol. 2017;407:153–189. PubMed PMID: 28550454; eng.
   PubMed Web of Science ®Google Scholar
• Ersahin T, Tuncbag N, Cetin-Atalay R. The PI3K/AKT/mTOR interactive pathway. Mol Biosyst. 2015 Jul;11(7):1946–1954. PubMed PMID: 25924008; eng.
   PubMedGoogle Scholar
• Guo H, Zhou T, Jiang D, et al. Regulation of hepatitis B virus replication by the phosphatidylinositol 3-kinase-akt signal transduction pathway. J Virol. 2007 Sep;81(18):10072–10080. PubMed PMID: 17609269; PubMed Central PMCID: PMCPMC2045390. eng.
   PubMed Web of Science ®Google Scholar
• Liu H, Xu J, Zhou L, et al. Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway. Cancer Res. 2011;71(24):7547–7557.
   PubMed Web of Science ®Google Scholar
• Li M, Sun X-H, Zhu X-J, et al. HBcAg induces PD-1 upregulation on CD4+ T cells through activation of JNK, ERK and PI3K/AKT pathways in chronic hepatitis-B-infected patients. Lab Invest. 2012;92(2):295.
   PubMed Web of Science ®Google Scholar
• Qu C, Zheng D, Li S, et al. Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology. 2018;68(3):1125–1139. PubMed PMID: 29537660.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Mori N, Tamesa T, et al. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Mod Pathol. 2004;17(6):617–622. PubMed PMID: 15133472.
   PubMed Web of Science ®Google Scholar
• Chang TS, Wu YC, Chi CC, et al. Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression. Clin Cancer Res off J Am Assoc Cancer Res. 2015;21(1):201–210. PubMed PMID: 25564572.
   PubMed Web of Science ®Google Scholar